A lawyer for the U.S. Chamber of Commerce on Friday urged a federal judge to block President Joe Biden's administration from implementing a new program that would let Medicare negotiate prices with ...

The Chamber of Commerce urged a federal judge on Friday to stop the new Medicare drug price negotiation program before Oct. 1 ...

Drug companies challenging the law in court could still have several chances to stop the program before next year's election.

Infusion therapy providers would be harmed if a federal judge dismisses a lawsuit challenging Medicare’s new drug price ...

PhRMA, a leading drug industry trade group, and the US Chamber of Commerce have also filed suits. More on Medicare drug pricing: Medicare lists first ten drugs selected for pricing negotiations ...

Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...

There are a slew of federal programs and staff that could see work stalled this week. Is Biden’s signature drug pricing program on the outs too?

A group of Republicans has called the Biden administration's list of the first 10 drugs that will face Medicare price negotiations a form of price controls that will end up leading to fewer new ...

The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking a swipe at the powerful pharmaceutical industry. It marks a major ...

We decided that there's no reason to shut it down,” said Chamber President Diane Bruce, who assumed the role on a part-time ...

Showcasing projects worth billions of dollars, Africa Investment Forum drums up global investor interest ahead of Market Days ...

Japanese drugmaker Astellas (OTCPK:ALPMF) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly ...